Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

We said to buy shares in early July 2024, when the stock had gotten knocked down to $192. The market was concerned a new Eli Lilly pill would reduce patients’ obstructive sleep apnea, or OSA, enough ...

Battered by multiple years of high health care costs, employers are planning to shift more of the expense to workers in 2026.

Workers' health care costs may increase next year as employers cut health benefits to cope with rising expenses.

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

YoCrunch yogurt products are being pulled from store shelves nationwide due to a safety concern -- plastic in the dome -- its ...

There is a precedent here — ironically from Chicago-based Mondelez. After Kraft was spun off, Mondelez retained the sexier ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The Ohio Department of Administrative Services announced state employees’ Medicaid coverage for GLP-1 obesity management ...

Albertsons CEO Susan Morris said she had to "double-check the numbers" when she saw how much cottage cheese the chain was selling.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...